학술논문
Nonclinical toxicology assessments support the chronic safety of dapagliflozin, a first-in-class sodium-glucose cotransporter 2 inhibitor
Document Type
Article
Author
Source
In: International Journal of Toxicology . (International Journal of Toxicology, September 2013, 32(5):336-350)
Subject
Language
English
ISSN
10915818
1092874X
1092874X